Global B2B Pharmaceutical Marketplace Β· Sourcing Β· Named-Patient Access
πŸ’¬ WhatsApp Β· Sign in Β· Register

Comparator Sourcing & Clinical Trial Supply

Comparator and reference products sourced from the market your protocol specifies, with validated chain of custody, batch consistency and the import documentation your sites actually need.

Mitul Agarwal
Written by Mitul Agarwal Β· B.Pharm, MBA
Founder & Head of Business Development Β· 25+ years in international pharmaceutical BD&L

Comparator supply is a documentation problem, not a purchasing problem

Buying a licensed innovator product is easy. Buying it in a way that will survive a regulatory inspection of your trial is not. The comparator has to come from an acceptable market, carry an unbroken chain of custody back to a legitimate distribution channel, and ideally come from a single batch with enough remaining shelf life to cover the whole study.

Those constraints are what make comparator sourcing slow, and they are where studies get held up. A comparator obtained cheaply through an unverifiable channel is worth nothing if the sponsor cannot demonstrate provenance later.

We work backwards from the protocol and the inspection requirement, not from the price list.

What holds studies up
  • Comparator sourced from a market the protocol does not accept
  • Multiple batches where the protocol assumed one
  • Residual shelf life shorter than the study duration
  • Chain of custody with an unverifiable link
  • Missing Certificate of Conformity or Authenticity
  • Import permit not secured before the shipment moves
  • Labelling that does not meet the destination's trial requirements

What we supply

Comparator products

Innovator and reference-listed products sourced from the specific market your protocol or regulator requires, with country of purchase documented.

Reference standards

Pharmacopoeial and working reference standards for APIs, excipients and impurities, supplied with certification and stability-preserved packaging.

Biologics & vaccines

Temperature-controlled comparator biologics and vaccine references, with continuous data-logger records and qualified shipping systems.

Ancillary supplies

Rescue and background medication, placebo-matching support, and co-administered products needed to run the protocol.

Documentation for trial supply

  • Certificate of Conformity
  • Certificate of Authenticity
  • Batch-specific Certificate of Analysis
  • Documented chain of custody from point of purchase
  • Country of purchase and distribution channel record
  • Invoice and packing list matched to batch and quantity
  • Continuous temperature record where applicable
  • Import permit and licence support for the destination
  • Remaining shelf-life declaration at dispatch
  • Original manufacturer packaging retained and photographed

See the full documentation and quality pack

How a comparator project runs

1
Protocol and constraint review

Which markets are acceptable as a source, is single-batch supply required, what is the minimum shelf life at last dose, and what does the destination regulator require for import of trial material.

2
Availability and batch check

We confirm real availability of a single batch in sufficient quantity with adequate residual shelf life, before quoting. Where a single batch is not achievable we say so early so the protocol can be adjusted rather than the study delayed.

3
Quotation with reservation

Price, batch details, shelf life and lead time quoted together, with the stock reserved for a defined period so it does not disappear during your approval cycle.

4
Procurement with custody record

Purchase through a licensed distribution channel with each transfer documented, original packaging retained and photographed, and storage conditions logged throughout.

5
Import clearance and delivery

Permit and licence support for the receiving country, qualified shipping system for temperature-sensitive material, and delivery to your depot, CRO or investigator site as instructed.

6
Resupply and top-up

Where enrolment extends or sites are added, we hold source details on file so a top-up can be matched to the original batch wherever it remains available.

Who we work with

  • Sponsors running multi-country studies needing consistent comparator supply
  • CROs and clinical supply teams managing sourcing on a sponsor's behalf
  • Bioequivalence centres requiring a locally acceptable reference product
  • Academic and biotech R&D groups needing reference standards with full traceability
  • Generic developers sourcing the innovator product for comparative studies

Send us your comparator requirement

Product, strength, quantity, acceptable source markets, required shelf life and destination country. We will confirm availability and batch position before quoting.

Submit Study Requirement Talk to our team

Frequently Asked Questions

A comparator is the existing product an investigational treatment is measured against β€” typically the licensed innovator product, or a reference-listed product specified by the regulator. Because the comparison underpins the study result, regulators expect the sponsor to be able to demonstrate exactly what was purchased, from which market and through which distribution channel.

Using one batch across a study removes batch-to-batch variability as a confounding factor and simplifies the documentation the sponsor has to maintain. It is not always achievable β€” batch availability in the required quantity with sufficient remaining shelf life is a real constraint β€” which is why we confirm the batch position before quoting rather than discovering it during fulfilment.

Chain of custody is the documented record of every transfer of the material from its original purchase through to the investigator site, including storage conditions at each stage. Inspectors ask for it because it is the only way to establish that the comparator was genuine, correctly stored and not substituted. A gap in that record can call the comparative data into question, which is why provenance matters more than price on comparator purchases.

Usually yes, and it is often a protocol requirement rather than a preference β€” some regulators will only accept a reference product sourced from their own market or from a defined list of markets. Tell us the acceptable source markets at the outset, because it materially affects availability, price and lead time.

Yes. Bioequivalence work often needs a modest quantity of a specific reference product from a specific market, with full documentation. There is no minimum order requirement for comparator and reference supply β€” the documentation burden is much the same whether the order is small or large.

Cold-chain and controlled-temperature comparators ship in qualified packaging with continuous data-logger monitoring, and the temperature record is supplied on delivery so your QA can review excursions before the material is released for use. Full detail is on our cold chain logistics page.

Yes, to whichever the sponsor nominates β€” central depot, CRO facility, or individual investigator sites in multiple countries. Multi-country delivery needs import permits handled per destination, so the earlier the site list is confirmed, the smoother the shipment schedule.

Comparator and reference material is supplied for research and clinical study use by qualified organisations. We do not supply medicines to individuals, and nothing on this page constitutes medical advice or a recommendation for patient treatment.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.